Welcome to our dedicated page for CARDINAL HEALTH SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cardinal Health, Inc. filings document material events for a healthcare distribution and medical products company, including quarterly results, Regulation FD outlook updates and earnings presentation exhibits. The records tie financial reporting to segment performance, capital returns, debt reduction and corporate finance matters such as revolving credit agreements that support the commercial paper program.
Governance filings cover board composition, annual meeting voting results, director and officer transitions, and related compensation or succession disclosures. The company’s 8-K record also includes material definitive agreements, shareholder voting matters, financial covenants, exhibits and other capital-structure disclosures for Cardinal Health’s public-company profile.
Vanguard Capital Management reported beneficial ownership of 17,635,857 shares of Cardinal Health common stock, representing 7.49% of the class as reported on this Schedule 13G. The filing shows sole dispositive power over 17,635,857 shares and sole voting power over 2,347,148 shares. The filing is signed on 04/29/2026.
Cardinal Health Inc Schedule 13G: Vanguard Portfolio Management reports beneficial ownership of 13,786,683 shares of Common Stock, representing 5.85% of the class as reported. The filing shows sole voting power for 54,374 shares and sole dispositive power for 13,786,683 shares. The disclosure states these holdings reflect securities managed or advised by Vanguard Portfolio Management LLC and specified affiliates and fund sleeves.
Hall Patricia Hemingway reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health director Patricia Hemingway Hall reported an equity award rather than an open-market trade. She received 381 Common Shares in the form of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026, at a reference price of $207.83 per share. Following this grant, she directly holds 28,645 Common Shares.
The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A regarding Cardinal Health Inc. Common Stock. The filing states that, following an internal realignment effective January 12, 2026, The Vanguard Group reports 0 shares beneficially owned and 0% of the class. The amendment explains certain subsidiaries and business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998), and that The Vanguard Group no longer is deemed to have beneficial ownership over securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Cardinal Health, Inc. reported that on March 2, 2026, Senior Vice President and Chief Accounting Officer Mary Scherer notified the company of her intention to retire in February 2027. The company plans to conduct a search for her successor.
Scherer will continue serving as Chief Accounting Officer until a new executive is identified and onboarded to support a smooth transition in the company’s accounting leadership.
Cardinal Health Chief Information Officer Michelle D. Greene reported two open-market sales of Cardinal Health common shares. On February 27, 2026, she sold 100 shares at $228.55 and 2,646 shares at $228.47, for a total of 2,746 shares sold. After these transactions, she directly owned 12,230 common shares of Cardinal Health.
Cardinal Health, Inc. submitted a Form 144 notice indicating a proposed sale of 2,746 common shares with a filing date of 02/27/2026. The disclosure lists restricted stock vesting events of 1,973 shares on 08/15/2024 and 773 shares on 03/15/2024.
Cardinal Health Chief Financial Officer Aaron E. Alt reported two recent transactions in the company’s common shares. On February 18, 2026, he completed an open-market sale of 2,328 shares at an average price of $225.50 per share. On February 15, 2026, 1,914 shares were disposed of to cover tax withholding obligations tied to the vesting of 4,242 restricted share units, using a price of $220.79 per share that reflects the prior business day’s close. After these transactions, Alt directly owns 26,408 common shares of Cardinal Health.